Factors affecting use of magnesium sulphate for pre‐eclampsia or eclampsia: a qualitative evidence synthesis

KE Eddy, JP Vogel, RI Zahroh… - BJOG: An International …, 2022 - Wiley Online Library
… Within each COM-B domain, we mapped facilitators and barriers to physical and … 4 ,
especially given that administration requires ongoing monitoring for toxicity. Staffing constraints are …

[HTML][HTML] Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework

E Bain, T Bubner, P Ashwood, E Van Ryswyk… - BMC pregnancy and …, 2015 - Springer
… This Project is ongoing and comprises a package of active implementation strategies to
guide the introduction and local adaptation of guideline recommendations, and to monitor and …

Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand–Ongoing barriers and enablers

K Gatman, R May, C Crowther - Australian and New Zealand …, 2020 - Wiley Online Library
… use of magnesium sulphate for fetal neuroprotection has continued to increase since the
earlier, bi-national survey in 2012. Barriers to the use of magnesium sulphate identified have …

[HTML][HTML] Magnesium sulphate for fetal neuroprotection: benefits and challenges of a systematic knowledge translation project in Canada

…, LA Magee, MAG-CP Collaborative Group - BMC Pregnancy and …, 2015 - Springer
barriers, the ‘Barriers and Facilitators’ survey provided more detail regarding social-level
barriers. … Comparison with data audit is currently ongoing. As audit and feedback are essential …

[HTML][HTML] Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia

M Aaserud, S Lewin, S Innvaer, EJ Paulsen… - BMC health services …, 2005 - Springer
barriers within the health system, such as drug availability and licensing, this study demonstrates
that the availability of magnesium sulphate … could provide an ongoing framework and …

[HTML][HTML] Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study

O Oguntunde, Z Charyeva, M Cannon… - BMC pregnancy and …, 2015 - Springer
… facilitators and barriers to the use of magnesium sulphate (… Furthermore, 9 % of providers
reported an ongoing stock-out … , and was an important barrier to the management of PE/E. …

[HTML][HTML] MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada

…, MAG-CP, CPN and CNN collaborative groups… - Implementation …, 2018 - Springer
… five nurses (to explore local barriers to and facilitators of MAG-CP … The audit and feedback
cycle to address local barriers … ), thus creating the audit cycle to inform and fuel ongoing KT. …

[HTML][HTML] A systematic review of magnesium sulfate for perinatal neuroprotection: what have we learnt from the past decade?

R Galinsky, JM Dean, I Lingam, NJ Robertson… - Frontiers in …, 2020 - frontiersin.org
… , greater dysfunction of the blood brain barrier and proteolysis (40, 60). … trials is ongoing
(The MagCool Study; NCT01646619) (36, 37). … Magnesium sulphate and cardiovascular and …

Use of magnesium sulfate before 32 weeks of gestation: a European population-based cohort study

HT Wolf, L Huusom, T Weber, A Piedvache… - BMJ open, 2017 - bmjopen.bmj.com
… High-income countries have fewer barriers for accessing … for the results of an ongoing
randomised controlled trial from … . Antenatal magnesium sulphate may prevent cerebral palsy …

[HTML][HTML] Magnesium chloride or magnesium sulfate: a genuine question

J Durlach, A Guiet-Bara, N Pagès, P Bac, M Bara - Magnesium research, 2005 - jle.com
… associated with magnesium other than sulphate could have a … supporting data and the
ongoing absence of an international … and the effects of both magnesium sulphate and chloride. …